Login

Login

Generate password

Change password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Eiko Lifesciences Ltd.

NSE : BSE : 540204 ISIN CODE : INE666Q01016Industry : Chemicals - Speciality

News

  • Eiko Lifesciences - Revised Financial Results For Quarter And Year Ended 31St March, 2025 14 May 2025 | 20:19 | Dion Global

    Due to typographical error the company inadvertently mentioned wrong numbers in few lines of financial results as mentioned in Annexure I. Please not...more...

  • Eiko Lifesciences - Revise Outcome Of Board Meeting Dated 14.05.2025 14 May 2025 | 20:14 | Dion Global

    Due to typographical error the company inadvertently mentioned wrong number in few lines of Financial results as mentioned in Annexure I. Pl...more...

  • Eiko Lifesciences - Appointment Of Secretarial Auditor 14 May 2025 | 19:20 | Dion Global

    Appointment of M/S Shravan Gupta as Secretarial Auditor for a period of 5 years from FY 2025-26more...

  • Eiko Lifesciences - Appointment Of Internal Auditor 14 May 2025 | 19:17 | Dion Global

    Appointment of Narendra Rajput as Internal Auditor for FY 25-26more...

  • Eiko Lifesciences Q4 net profit zooms 190.32% at Rs 0.90 cr 14 May 2025 | 16:50 | Dion Global

    The company reported standalone net profit of Rs 0.90 crore for the quarter ended March 31 2025 as compared to Rs 0.31 crore in the same period last ...more...

  • Eiko Lifesciences - Results For Quarter And Year Ended 31St March 2025 14 May 2025 | 16:49 | Dion Global

    Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2025more...

  • Eiko Lifesciences - Board Meeting Outcome for Outcome Of Board Meeting Dated 14.05.2025 14 May 2025 | 16:38 | Dion Global

    Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ( ...more...

  • Eiko Lifesciences - Board Meeting Intimation for Approval Of Financial Results And Other Agendas 07 May 2025 | 19:20 | Dion Global

    Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to con...more...

  • Eiko Lifesciences - Submission Of Initial And Annual Disclosure As Per SEBI Circular- - Fund Raising By Issuance Issuance Of 16 Apr 2025 | 18:25 | Dion Global

    Pursuant to SEBI circular Eiko Lifesciences Ltd is not a Large Corporate. Hence filing of initial and annual disclosure does not arise.more...

  • Eiko Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025 15 Apr 2025 | 16:50 | Dion Global

    As of March 2025 36.23% is owned by Indian Promoters and 63.77% by Public. Top five Promoters holding highest number of shares of Eiko Lifes...more...

  • Eiko Lifesciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 07 Apr 2025 | 18:58 | Dion Global

    Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations 2018more...

  • Eiko Lifesciences - Announcement under Regulation 30 (LODR)-Change in Directorate 12 Mar 2025 | 17:35 | Dion Global

    The company has taken note of appointment of Mr. Rajkumar Govindas Baheti (DIN: 05164182) an Independent Director of the Eiko Lifesciences L...more...

  • Eiko Lifesciences - Newspaper Publication 14 Feb 2025 | 12:12 | Dion Global

    Pursuant to reg 47 & 30 of SEBI (LODR) Financial Results for quarter and nine months ended 31st December 2024 has been published in Financial Express...more...

  • Eiko Lifesciences Q3 net profit up 16.67% at Rs 0.28 cr 13 Feb 2025 | 10:50 | Dion Global

    The company reported standalone net profit of Rs 0.28 crore for the quarter ended December 31 2024 as compared to Rs 0.24 crore in the same ...more...

  • Eiko Lifesciences - Integrated Filing (Financial) 12 Feb 2025 | 20:52 | Dion Global

    Integrated Financials for quarter and nine months ended 31st December 2024more...

  • Eiko Lifesciences - Nil Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of The SEBI (Listing Obligations And Di 12 Feb 2025 | 20:49 | Dion Global

    Nil statement of Deviation for quarter and nine months ended 31st December 2024more...

  • Eiko Lifesciences - Financial Results For Quarter And Nine Months Ended 31St December, 2024 12 Feb 2025 | 20:45 | Dion Global

    Financial Results for Quarter and nine months ended 31st December 2024more...

  • Eiko Lifesciences - Board Meeting Outcome for Outcome Of Board Meetinng 12 Feb 2025 | 20:42 | Dion Global

    Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 20...more...

  • Eiko Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended January 24, 2025 29 Jan 2025 | 22:00 | Dion Global

    As of January 2025 31.27% is owned by Indian Promoters and 68.73% by Public. Top five Promoters holding highest number of shares of Eiko Lifesciences...more...

  • Eiko Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended January 24, 2025 29 Jan 2025 | 22:00 | Dion Global

    As of January 2025 31.27% is owned by Indian Promoters and 68.73% by Public. Top five Promoters holding highest number of shares of Eiko Lif...more...

Enter Stock

DOW Jones42506.260.73%
Nasdaq19681.151.41%
S&P 5006027.260.84%
Nikkei 22538311.331.26%
Hang Seng24028.370.57%
Shanghai Composite3388.730.35%
Sensex81796.150.84%
NSE Index24946.50.92%
BSE 100LCTMC9216.330.86%
BSE Auto 52378.020.10%
BSE Bharat228571.810.96%
BSE CPSE 3922.070.89%

Commodity

Gold987322.00%
Silver1059120.88%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 86.02(-0.08 %)
GBP/INR 116.75(0.16 %)
EUR/INR 99.40(0.08 %)
JPY/INR 0.60(-0.53 %)
CAD/INR 62.88(0.00 %)
HKD/INR 10.90(0.00 %)